CareDx, Inc. is a pharmaceutical company based in the United States, specializing in precision medicine solutions for transplant patients and their caregivers. They offer a range of testing services, products, and digital solutions to enhance the pre-and post-transplant patient journey. CareDx is known for providing genomics-based information to transplant patients. The company's ESG score is 25.3, categorizing it as a medium risk in terms of environmental, sustainability, and governance factors. The majority of their revenue comes from Testing services.